The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Epigenetic drivers of tumourigenesis and cancer metastasis
Open accessAbstract
Since the completion of the first human genome sequence and the advent of next generation sequencing technologies, remarkable progress has been made in understanding the genetic basis of cancer. These studies have mainly defined genetic changes as either causal, providing a selective advantage to the cancer cell (a driver mutation) or consequential with no selective advantage (not directly causal, a passenger mutation). A vast unresolved question is how a primary cancer cell becomes metastatic and what are the molecular events that underpin this process. However, extensive sequencing efforts indicate that mutation may not be a causal factor for primary to metastatic transition. On the other hand, epigenetic changes are dynamic in nature and therefore potentially play an important role in determining metastatic phenotypes and this area of research is just starting to be appreciated. Unlike genetic studies, current limitations in studying epigenetic events in cancer metastasis include a lack of conceptual understanding and an analytical framework for identifying putative driver and passenger epigenetic changes. In this review, we discuss the key concepts involved in understanding the role of epigenetic alterations in the metastatic cascade. We particularly focus on driver epigenetic events, and we describe analytical approaches and biological frameworks for distinguishing between "epi-driver" and "epi-passenger" events in metastasis. Finally, we suggest potential directions for future research in this important area of cancer research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Comprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13480 · Cited by 6,498
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain
Kriaucionis, S., & Heintz, N. (2009) · Science · doi:10.1126/science.1169786 · Cited by 2,700
Metastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2622 · Cited by 2,649
Sharma, S., Kelly, T. K., & Jones, P. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp220 · Cited by 2,637
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605
A molecular signature of metastasis in primary solid tumors
Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,449
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Chiappinelli, K. B., Strissel, P. L., Desrichard, A., Li, H., Henke, C., Akman, B., Hein, A., Rote, N. S., Cope, L. M., Snyder, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.011 · Cited by 2,022
Metastasis: a question of life or death
Mehlen, P., & Puisieux, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1886 · Cited by 1,863
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
Baylin, S. B., & Ohm, J. E. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1799 · Cited by 1,639
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
Versteege, I., Sévenet, N., Lange, J., Rousseau-Merck, M.-F., Ambros, P., Handgretinger, R., Aurias, A., & Delattre, O. (1998) · Nature · doi:10.1038/28212 · Cited by 1,556
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,529
Roulois, D., Loo Yau, H., Singhania, R., Wang, Y., Danesh, A., Shen, S. Y., Han, H., Liang, G., Jones, P. A., Pugh, T. J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.056 · Cited by 1,527
Kane, M., Loda, M. F., Gaida, G. M., Lipman, J., Mishra, R., Goldman, H., Jessup, J. M., & Kolodner, R. D. (1997) · PubMed · Cited by 1,476
Chromosomal Instability and Tumors Promoted by DNA Hypomethylation
Eden, A., Gaudet, F., Waghmare, A., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083557 · Cited by 1,399
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
Challenges in circulating tumour cell research
Alix-Panabières, C., & Pantel, K. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3820 · Cited by 1,300
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Peng, D., Kryczek, I., Nagarsheth, N., Zhao, L., Wei, S., Wang, W., Sun, Y., Zhao, E., Vatan, L., Szeliga, W., et al. (2015) · Nature · doi:10.1038/nature15520 · Cited by 1,201
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Yang, X., Han, H., De Carvalho, D. D., Lay, F. D., Jones, P. A., & Liang, G. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.028 · Cited by 1,199
Transcriptional Addiction in Cancer
Bradner, J. E., Hnisz, D., & Young, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.12.013 · Cited by 1,194
A microRNA DNA methylation signature for human cancer metastasis
Lujambio, A., Calin, G. A., Villanueva, A., Ropero, S., Sánchez-Céspedes, M., Blanco, D., Montuenga, L. M., Rossi, S., Nicoloso, M. S., Faller, W. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803055105 · Cited by 1,078
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Interplay between the Cancer Genome and Epigenome
Shen, H., & Laird, P. W. (2013) · Cell · doi:10.1016/j.cell.2013.03.008 · Cited by 910
Genetic determinants of cancer metastasis
Nguyen, D. X., & Massagué, J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2101 · Cited by 801
Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
Epigenetic modifications as therapeutic targets
Kelly, T. K., De Carvalho, D. D., & Jones, P. A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1678 · Cited by 793
Standards of care for treatment of recurrent glioblastoma—are we there yet?
Weller, M., Cloughesy, T., Perry, J. R., & Wick, W. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos273 · Cited by 771
Toward understanding and exploiting tumor heterogeneity
Alizadeh, A. A., Aranda, V., Bardelli, A., Blanpain, C., Bock, C., Borowski, C., Caldas, C., Califano, A., Doherty, M., Elsner, M., et al. (2015) · Nature Medicine · doi:10.1038/nm.3915 · Cited by 746
Epigenetic gene silencing in cancer: the DNA hypermethylome
Esteller, M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm018 · Cited by 725
Parallel single-cell sequencing links transcriptional and epigenetic heterogeneity
Angermueller, C., Clark, S. J., Lee, H. J., Macaulay, I. C., Teng, M. J., Hu, T. X., Krueger, F., Smallwood, S. A., Ponting, C. P., Voet, T., et al. (2016) · Nature Methods · doi:10.1038/nmeth.3728 · Cited by 717
bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia
Hanada, M., Delia, D., Aiello, A., Stadtmauer, E., & Reed, J. (1993) · Blood · doi:10.1182/blood.v82.6.1820.1820 · Cited by 673
Pharoah, P. D. P., Guilford, P., & Caldas, C. (2001) · Gastroenterology · doi:10.1053/gast.2001.29611 · Cited by 638
Tumour hypoxia causes DNA hypermethylation by reducing TET activity
Thienpont, B., Steinbacher, J., Zhao, H., D’Anna, F., Kuchnio, A., Ploumakis, A., Ghesquière, B., Van Dyck, L., Boeckx, B., Schoonjans, L., et al. (2016) · Nature · doi:10.1038/nature19081 · Cited by 635
Molecular analysis of circulating tumour cells—biology and biomarkers
Krebs, M. G., Metcalf, R. L., Carter, L., Brady, G., Blackhall, F. H., & Dive, C. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.253 · Cited by 622
Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host
Timp, W., & Feinberg, A. P. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3486 · Cited by 586
Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma
Greger, V., Passarge, E., H�pping, W., Messmer, E., & Horsthemke, B. (1989) · Human Genetics · doi:10.1007/bf00286709 · Cited by 574
Vanharanta, S., & Massagué, J. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.007 · Cited by 563
Liquid Biopsies, What We Do Not Know (Yet)
Bardelli, A., & Pantel, K. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.002 · Cited by 482
Gene number, noise reduction and biological complexity
Bird, A. P. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89009-5 · Cited by 463
DNA methylation pattern changes upon long‐term culture and aging of human mesenchymal stromal cells
Bork, S., Pfister, S., Witt, H., Horn, P., Korn, B., Ho, A. D., & Wagner, W. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2009.00535.x · Cited by 409
Makohon-Moore, A. P., Zhang, M., Reiter, J. G., Bozic, I., Allen, B., Kundu, D., Chatterjee, K., Wong, F., Jiao, Y., Kohutek, Z. A., et al. (2017) · Nature Genetics · doi:10.1038/ng.3764 · Cited by 403
Comparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene
Kim, M., Gans, J. D., Nogueira, C., Wang, A., Paik, J.-H., Feng, B., Brennan, C., Hahn, W. C., Cordon-Cardo, C., Wagner, S. N., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.008 · Cited by 392
Alterations of immune response of non-small cell lung cancer with Azacytidine
Wrangle, J., Wang, W., Koch, A., Easwaran, H., Mohammad, H. P., Pan, X., Vendetti, F., VanCriekinge, W., DeMeyer, T., Du, Z., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1542 · Cited by 386
Cancer Development, Progression, and Therapy: An Epigenetic Overview
Sarkar, S., Horn, G., Moulton, K., Oza, A., Byler, S., Kokolus, S., & Longacre, M. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141021087 · Cited by 386
The first five years of single-cell cancer genomics and beyond
Navin, N. E. (2015) · Genome Research · doi:10.1101/gr.191098.115 · Cited by 371
Zingg, D., Debbache, J., Schaefer, S. M., Tuncer, E., Frommel, S. C., Cheng, P., Arenas-Ramirez, N., Haeusel, J., Zhang, Y., Bonalli, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7051 · Cited by 334
DNA Methylation: An Alternative Pathway to Cancer
Wajed, S. A., Laird, P. W., & DeMeester, T. R. (2001) · Annals of Surgery · doi:10.1097/00000658-200107000-00003 · Cited by 327
Simpkins, S. B., Bocker, T., Swisher, E. M., Mutch, D. G., Gersell, D. J., Kovatich, A. J., Palazzo, J. P., Fishel, R., & Goodfellow, P. J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.661 · Cited by 319
Targeting of Lung Cancer Mutational Hotspots by Polycyclic Aromatic Hydrocarbons
Smith, L. E., Denissenko, M. F., Bennett, W. P., Li, H., Amin, S., Tang, M.-S., & Pfeifer, G. P. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.10.803 · Cited by 307
DNA Methylation Screening Identifies Driver Epigenetic Events of Cancer Cell Survival
De Carvalho, D. D., Sharma, S., You, J. S., Su, S.-F., Taberlay, P. C., Kelly, T. K., Yang, X., Liang, G., & Jones, P. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.045 · Cited by 285
Super-Enhancer-Mediated RNA Processing Revealed by Integrative MicroRNA Network Analysis
Suzuki, H. I., Young, R. A., & Sharp, P. A. (2017) · Cell · doi:10.1016/j.cell.2017.02.015 · Cited by 284
Aryee, M. J., Liu, W., Engelmann, J. C., Nuhn, P., Gurel, M., Haffner, M. C., Esopi, D., Irizarry, R. A., Getzenberg, R. H., Nelson, W. G., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005211 · Cited by 275
Im, A. P., Sehgal, A. R., Carroll, M. P., Smith, B. D., Tefferi, A., Johnson, D. E., & Boyiadzis, M. (2014) · Leukemia · doi:10.1038/leu.2014.124 · Cited by 267
Intratumor DNA Methylation Heterogeneity Reflects Clonal Evolution in Aggressive Prostate Cancer
Brocks, D., Assenov, Y., Minner, S., Bogatyrova, O., Simon, R., Koop, C., Oakes, C., Zucknick, M., Lipka, D. B., Weischenfeldt, J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.053 · Cited by 260
Circulating tumour cells: their utility in cancer management and predicting outcomes
Krebs, M. G., Hou, J.-M., Ward, T. H., Blackhall, F. H., & Dive, C. (2010) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834010378414 · Cited by 259
Mutational Heterogeneity in Human Cancers: Origin and Consequences
Salk, J. J., Fox, E. J., & Loeb, L. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102113 · Cited by 249
Dumont, N., Wilson, M. B., Crawford, Y. G., Reynolds, P. A., Sigaroudinia, M., & Tlsty, T. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807146105 · Cited by 210
Identifying cancer driver genes in tumor genome sequencing studies
Youn, A., & Simon, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btq630 · Cited by 201
Epigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential
Kazanets, A., Shorstova, T., Hilmi, K., Marques, M., & Witcher, M. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.04.001 · Cited by 195
Driver mutations of cancer epigenomes
Roy, D. M., Walsh, L. A., & Chan, T. A. (2014) · Protein & Cell · doi:10.1007/s13238-014-0031-6 · Cited by 186
Pan-cancer patterns of DNA methylation
Witte, T., Plass, C., & Gerhauser, C. (2014) · Genome Medicine · doi:10.1186/s13073-014-0066-6 · Cited by 175
Rapid reprogramming of epigenetic and transcriptional profiles in mammalian culture systems
Nestor, C. E., Ottaviano, R., Reinhardt, D., Cruickshanks, H. A., Mjoseng, H. K., McPherson, R. C., Lentini, A., Thomson, J. P., Dunican, D. S., Pennings, S., et al. (2015) · Genome Biology · doi:10.1186/s13059-014-0576-y · Cited by 173
Epigenetic drivers and genetic passengers on the road to cancer
Sawan, C., Vaissière, T., Murr, R., & Herceg, Z. (2008) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2008.03.002 · Cited by 166
Personalized treatment strategies in glioblastoma: MGMT promoter methylation status
Thon, N., Kreth, S., & Kreth, F. W. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s50208 · Cited by 166
Nishigaki, M., Aoyagi, K., Danjoh, I., Fukaya, M., Yanagihara, K., Sakamoto, H., Yoshida, T., & Sasaki, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3340 · Cited by 160
Transcriptional control of cancer metastasis
Ell, B. J., & Kang, Y. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.06.001 · Cited by 147
CanPredict: a computational tool for predicting cancer-associated missense mutations
Kaminker, J. S., Zhang, Y., Watanabe, C., & Zhang, Z. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm405 · Cited by 146
Hurst, D. R., & Welch, D. R. (2011) · International review of cytology · doi:10.1016/b978-0-12-385859-7.00003-3 · Cited by 141
Vizoso, M., Ferreira, H. J., López-Serra, P., Carmona, F. J., Martínez‐Cardús, A., Girotti, M. R., Villanueva, A., Guil, S., Moutinho, C., Liz, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3863 · Cited by 126
Enhancer methylation dynamics contribute to cancer plasticity and patient mortalityPreprint
Bell, R. E., Golan, T., Sheinboim, D., Malcov, H., Amar, D., Salamon, A., Liron, T., Gelfman, S., Gabet, Y., Ron Shamir, A., et al. (2016) · Genome Research · doi:10.1101/gr.197194.115 · Cited by 122
Mor, M., Nardone, S., Sams, D. S., & Elliott, E. (2015) · Molecular Autism · doi:10.1186/s13229-015-0040-1 · Cited by 118
Leichter, A., Sullivan, M., Eccles, M., & Chatterjee, A. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0584-0 · Cited by 112
Self-citationSmith, I. M., Glazer, C. A., Mithani, S. K., Ochs, M. F., Sun, W., Bhan, S., Vostrov, A. A., Abdullaev, Z., Lobanenkov, V. V., Gray, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004961 · Cited by 108
Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy
Maio, M., Covre, A., Fratta, E., Giacomo, A. M. D., Taverna, P., Natali, P. G., Coral, S., & Sigalotti, L. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2914 · Cited by 102
Cheng, P. F., Shakhova, O., Widmer, D. S., Eichhoff, O. M., Zingg, D., Frommel, S. C., Belloni, B., Raaijmakers, M. I., Goldinger, S. M., Santoro, R., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0594-4 · Cited by 100
The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer
Gao, D., Herman, J. G., & Guo, M. (2016) · Oncotarget · doi:10.18632/oncotarget.7949 · Cited by 98
Epigenetic regulation ofmicroRNA-10band targeting of oncogenicMAPRE1in gastric cancer
Kim, K., Lee, H., Park, J., Kim, S., Kim, S., Noh, S., Song, K., Kim, J. C., & Kim, S. (2011) · Epigenetics · doi:10.4161/epi.6.6.15874 · Cited by 92
Design and analysis issues in genome-wide somatic mutation studies of cancer
Parmigiani, G., Boca, S. M., Lin, J., Kinzler, K. W., Velculescu, V. E., & Vogelstein, B. (2008) · Genomics · doi:10.1016/j.ygeno.2008.07.005 · Cited by 90
Tools and Strategies for Analysis of Genome-Wide and Gene-Specific DNA Methylation Patterns
Chatterjee, A., Rodger, E. J., Morison, I. M., Eccles, M. R., & Stockwell, P. A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6685-1_15 · Cited by 89
Self-citationTargeted p16Ink4a epimutation causes tumorigenesis and reduces survival in mice
Yu, D.-H., Waterland, R. A., Zhang, P., Schady, D. A., Chen, M.-H., Guan, Y., Gadkari, M., & Shen, L. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76507 · Cited by 88
Rusek, A. M., Abba, M. L., Eljaszewicz, A., Moniuszko, M., Nikliński, J., & Allgayer, H. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0302-8 · Cited by 87
Zhang, Y., Chen, Y., Ahsan, H., Lunn, R. M., Lee, P., Chen, C., & Santella, R. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10852 · Cited by 86
Gray, E. S., Reid, A. L., Bowyer, S. E., Calapre, L., Siew, K. S. W., Pearce, R. L., Cowell, L., Frank, M. H., Millward, M., & Ziman, M. R. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.127 · Cited by 86
Tiffen, J. C., Gunatilake, D., Gallagher, S. J., Gowrishankar, K., Heinemann, A., Cullinane, C. M., Dutton‐Regester, K., Pupo, G. M., Strbenac, D., Yang, J. Y. H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4809 · Cited by 82
Chiappinelli, K. B., Strissel, P. L., Desrichard, A., Li, H., Henke, C., Akman, B., Hein, A., Rote, N. S., Cope, L., Snyder, A., et al. (2016) · Cell · doi:10.1016/j.cell.2015.10.020 · Cited by 80
Koslowski, M., Luxemburger, U., Türeci, Ö., & Şahin, U. (2010) · Oncogene · doi:10.1038/onc.2010.481 · Cited by 79
Analysis of DNA methylation in single circulating tumor cells
Pixberg, C. F., Raba, K., Müller, F., Behrens, B., Honisch, E., Niederacher, D., Neubauer, H. J., Fehm, T. N., Goering, W., Schulz, W. A., et al. (2017) · Oncogene · doi:10.1038/onc.2016.480 · Cited by 79
Promoter demethylation accompanies reactivation of theHOX11 proto-oncogene in leukemia
Watt, P. M., Kumar, R. G., & Kees, U. R. (2000) · Genes Chromosomes and Cancer · Cited by 77
A Comprehensive DNA Methylation Profile of Epithelial-to-Mesenchymal Transition
Carmona, F. J., Dávalos, V., Vidal, E., Gómez, A., Heyn, H., Hashimoto, Y., Vizoso, M., Martínez‐Cardús, A., Sayols, S., Ferreira, H. J., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3659 · Cited by 75
Chatterjee, A., Stockwell, P. A., Ahn, A., Rodger, E. J., Leichter, A. L., & Eccles, M. R. (2016) · Oncotarget · doi:10.18632/oncotarget.14042 · Cited by 73
Self-citationTechnical Considerations for Reduced Representation Bisulfite Sequencing with Multiplexed Libraries
Chatterjee, A., Rodger, E. J., Stockwell, P. A., Weeks, R. J., & Morison, I. M. (2012) · BioMed Research International · doi:10.1155/2012/741542 · Cited by 71
Self-citationLoriot, A. E., Tongelen, A. V., Blanco, J., Klaessens, S., Cannuyer, J., van Baren, N., Decottignies, A., & Smet, C. D. (2014) · Epigenetics · doi:10.4161/epi.29628 · Cited by 67
Studies of DNA methylation in animals
Bird, A. P., Tate, P. H., Nan, X., Campoy, J., Meehan, R. R., Cross, S. H., Tweedie, S., Charlton, J., & Macleod, D. (1995) · Journal of Cell Science · doi:10.1242/jcs.1995.supplement_19.5 · Cited by 67
Lee, J. J., Sholl, L. M., Lindeman, N. I., Granter, S. R., Laga, A. C., Shivdasani, P., Chin, G., Luke, J. J., Ott, P. A., Hodi, F. S., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0091-3 · Cited by 59
Epigenetic Modulators and the New Immunotherapies
Dear, A. E. (2016) · New England Journal of Medicine · doi:10.1056/nejmcibr1514673 · Cited by 57
In vivo-in vitro tumour cell lines: characteristics and limitations as models for human cancer.
Rockwell, S. (1980) · PubMed · Cited by 48
Tumor‐suppressive micro RNA silenced by tumor‐specific DNA hypermethylation in cancer cells
Kozaki, K., & Inazawa, J. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02236.x · Cited by 48
Remodeling of the Methylation Landscape in Breast Cancer Metastasis
Reyngold, M., Turcan, Ş., Giri, D. D., Kannan, K. S., Walsh, L. A., Viale, A. J., Drobnjak, M., Vahdat, L. T., Lee, W., & Chan, T. A.-T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103896 · Cited by 43
Epigenetic Regulation of microRNAs in Gastric Cancer
Ma, J., Hong, L., Chen, Z., Nie, Y., & Fan, D. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2939-8 · Cited by 36
Leichter, A. L., Purcell, R. V., Sullivan, M. J., Eccles, M. R., & Chatterjee, A. (2015) · GigaScience · doi:10.1186/s13742-015-0099-9 · Cited by 27
Self-citation5-Hydroxymethylcytosine: a Potential Therapeutic Target in Cancer
Rodger, E. J., Chatterjee, A., & Morison, I. M. (2014) · Epigenomics · doi:10.2217/epi.14.39 · Cited by 25
Self-citationEpigenetic Control of Angiogenesis via DNA Methylation
Cooper, M. P., & Keaney, J. F. (2011) · Circulation · doi:10.1161/circulationaha.111.033092 · Cited by 24
Chatterjee, A., Macaulay, E. C., Ahn, A., Ludgate, J. L., Stockwell, P. A., Weeks, R. J., Parry, M. F., Foster, T. J., Knarston, I. M., Eccles, M. R., et al. (2017) · Epigenomics · doi:10.2217/epi-2016-0176 · Cited by 17
Self-citationScan_Tcga Tools for Integrated Epigenomic and Transcriptomic Analysis of Tumor Subgroups
Chatterjee, A., Stockwell, P. A., Rodger, E. J., Parry, M. F., & Eccles, M. R. (2016) · Epigenomics · doi:10.2217/epi-2016-0063 · Cited by 15
Self-citation
Cited by
Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis
Hanniford, D., Ulloa-Morales, A., Karz, A., Berzoti-Coelho, M. G., Moubarak, R. S., Sánchez-Sendra, B., Kloetgen, A., Davalos, V., Imig, J., Wu, P., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2019.12.007 · Cited by 349
A framework for the development of effective anti-metastatic agents
Anderson, R. L., Balasas, T., Callaghan, J., Coombes, R. C., Evans, J., Hall, J. A., Kinrade, S., Jones, D., Jones, P. S., Jones, R., et al. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0134-8 · Cited by 341
Promoter DNA Hypermethylation and Paradoxical Gene Activation
Smith, J., Sen, S., Weeks, R. J., Eccles, M. R., & Chatterjee, A. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.02.007 · Cited by 274
Self-citationLung Cancer—Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature)
Smolarz, B., Łukasiewicz, H., Samulak, D., Piekarska, E., Kołaciński, R., & Romanowicz, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052049 · Cited by 259
Small nucleolar RNA and its potential role in breast cancer – A comprehensive review
Dsouza, V. L., Adiga, D., Sriharikrishnaa, S., Suresh, P. S., Chatterjee, A., & Kabekkodu, S. P. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188501 · Cited by 48
Self-citation
Metadata
- Authors
- Chatterjee, A., Rodger, E. J., & Eccles, M. R.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 51
- Pages
- 149-159
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2748237445
- Cited by
- 328
- References
- 116
- FWCI
- 8.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.